Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Home
Company
Product
Regulation
China
Data
Exhibition
Interview
中文版
Search

JTI Receives Global Top Employer Award for Tenth Consecutive Year

Events by 2FIRSTS.ai
Jan.18.2024
JTI Receives Global Top Employer Award for Tenth Consecutive Year
JTI, the Japanese tobacco multinational, has been awarded the Global Top Employer accolade for a record-breaking tenth consecutive year.

According to a report by Financial Post, Japan Tobacco International (JTI) has once again been awarded the prestigious Global Top Employer Award, marking its consecutive tenth year of receiving this accolade. Only seventeen global companies have been recognized with this honor, one of them being JTI, whose branches in eleven countries have all achieved first place rankings.

 

References:
[1] JTI Awarded Global Top Employer for the 10th Consecutive Year
Also Read:
[1] JTI Plans to Enter Korean HNB Market in H1 2024
[2] Japan Tobacco International Raises Cigarette Prices in Romania
[3] JTI Korea Considers Entry into Korean E-cigarette Market
#Asia#Market#Japan#JTI#Global#Employment

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

INTER-TABAC
INTER-TABAC
Imperial Brands Launches £1.45B Buyback Plan as New Product Revenue Jumps 12-14%
Imperial Brands Launches £1.45B Buyback Plan as New Product Revenue Jumps 12-14%
Imperial Brands: FY results in line; launches £1.45bn buyback (to Oct 2026). Constant-currency net revenue to grow low single digits; NGP +12%–14%; adjusted operating profit growth similar to last year’s 4.6%.
Oct.07 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace
FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace
At the FDLI Tobacco and Nicotine Policy Conference, FDA CTP Acting Director Bret Koplow spoke in favor of promoting tobacco harm reduction to reduce smoking. He backed a legal marketplace for authorized reduced-risk products, potential expansion of flavored e-cigs, and faster FDA reviews to ensure a strong, regulated market.
Oct.29 by 2FIRSTS.ai
Dagestan Proposes Pilot Ban on E-Cigarette Sales, Submits Request to State Duma
Dagestan Proposes Pilot Ban on E-Cigarette Sales, Submits Request to State Duma
The head of Russia’s Republic of Dagestan has proposed a region-wide ban on the retail sale of e-cigarettes and has written to the State Duma seeking to designate Dagestan as a pilot region for a comprehensive e-cigarette sales ban.
Oct.21 by 2FIRSTS.ai
InterTabac 2025｜Interview with Mylor Innovation Lab: Flavor Innovation × Compliance First, From Redefining Sourness to Global Expansion
InterTabac 2025｜Interview with Mylor Innovation Lab: Flavor Innovation × Compliance First, From Redefining Sourness to Global Expansion
At InterTabac 2025, Mylor Innovation Lab launched its JuiSour series of sourness solutions, attracting clients across Europe, the Middle East, etc. The JuiSour series enhance aroma and juiciness, and improve sour-sweet balance by reformulating the flavor, customizing the formulation and using a “Golden Sour-Sweet Ratio” model . Mylor emphasizes compliance and foresees two key trends “compliance-driven growth” and “flavor segmentation”, helping partners stand out in a homogenized global market.
Sep.19
The U.S. Department of Health and Human Services released a youth e-cigarette resource guide to address the proliferation of illegal products
The U.S. Department of Health and Human Services released a youth e-cigarette resource guide to address the proliferation of illegal products
U.S. HHS Surgeon General’s Office released a "Youth E-Cigarette Resource Guide" to tackle youth e-cig use. Though use fell, e-cigarettes are still middle/high schoolers’ top tobacco product—over 1.6M youth used them in 2024. Federal authorities seized millions of illegal devices, but sales persist, harming youth health. HHS and U.S. Customs recently seized $86.5M illegal e-cig products in a Chicago joint op.
Sep.16 by 2FIRSTS.ai
Related Topics
News Company
Related Read
Imperial Brands Launches £1.45B Buyback Plan as New Product Revenue Jumps 12-14%
Imperial Brands Launches £1.45B Buyback Plan as New Product Revenue Jumps 12-14%
2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
2FIRSTS.ai
FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace
FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace
2FIRSTS.ai
Dagestan Proposes Pilot Ban on E-Cigarette Sales, Submits Request to State Duma
Dagestan Proposes Pilot Ban on E-Cigarette Sales, Submits Request to State Duma
2FIRSTS.ai
InterTabac 2025｜Interview with Mylor Innovation Lab: Flavor Innovation × Compliance First, From Redefining Sourness to Global Expansion
InterTabac 2025｜Interview with Mylor Innovation Lab: Flavor Innovation × Compliance First, From Redefining Sourness to Global Expansion
The U.S. Department of Health and Human Services released a youth e-cigarette resource guide to address the proliferation of illegal products
The U.S. Department of Health and Human Services released a youth e-cigarette resource guide to address the proliferation of illegal products
2FIRSTS.ai
FOLLOW US ON SOCIAL MEDIA
Contact: info@2firsts.com
Stay up to date.
Submit your email to receive weekly newsletter on the most relevant news of the e-cigarette industry.
© 2025 Shenzhen 2FIRSTS Technology Co.,Ltd. All Right Reserved.
2FIRSTS is only accessible to industry practitioners, researchers, media and other professionals. Access by minors is prohibited.
This website provides services to users outside the Chinese mainland. For Chinese mainland users, please visit https://cn.2firsts.com
English
English
中文